Podcast Episodes
Back to SearchAntibodies For Severe Allergies With IgGenix's Jessica Grossman, M.D.
We love to hear from our listeners. Send us a message.
In this wide-ranging discussion, IgGenix CEO Jessica Grossman, M.D. discusses the application …
3 years, 9 months ago
Gene Therapies For Ocular Disease With Sparing Vision's Stéphane Boissel
We love to hear from our listeners. Send us a message.
Since assuming the President and CEO role at Sparingvision in August, 2020, Stéphane Boissel h…
3 years, 9 months ago
Biotech M&A Trends With Allan Shaw
We love to hear from our listeners. Send us a message.
On this episode of the Business of Biotech, Allan Shaw waxes on his expectations for mergers, …
3 years, 9 months ago
Lipid Nanoparticle Gene Coding With SalioGen Therapeutics' Ray Tabibiazar, M.D.
We love to hear from our listeners. Send us a message.
This episode of the Business of Biotech is fire. In fact, it's an interview with SalioGen Ther…
3 years, 10 months ago
CAR T-cells For Ovarian Cancer with Anixa Biosciences' Amit Kumar, Ph.D.
We love to hear from our listeners. Send us a message.
While success has been seen in animal models, solid tumors have proved a vexing challenge for …
3 years, 10 months ago
AI-Driven Biologics With Fountain Therapeutics' William Greene, M.D
We love to hear from our listeners. Send us a message.
With its hypothesis-free, target-free, AI-driven drug discovery platform, Fountain Therapeutic…
3 years, 10 months ago
Regulatory Harmonization With Aurion Biotech's Dr. Daniela Drago
We love to hear from our listeners. Send us a message.
If you're taking a candidate into clinical trials that will be monitored by multiple internati…
3 years, 10 months ago
Plant-Based Biologics With iBio's Randy Maddux
We love to hear from our listeners. Send us a message.
iBio COO Randy Maddux walks us through the Bryan, Texas-based biopharma's attempt to turn the …
3 years, 11 months ago
NK Cell Therapy Accessibility With Shoreline Biosciences' Dr. Kleanthis Xanthopoulos
We love to hear from our listeners. Send us a message.
Shoreline Biosciences CEO Kleanthis Xanthopoulos, Ph.D. joins the Business of Biotech to shar…
3 years, 11 months ago
A Hybrid mAb Manufacturing Model With John Glasspool
We love to hear from our listeners. Send us a message.
Post-operative venous thromboembolism (VTE) is a serious and prevalent post-operative risk tha…
3 years, 11 months ago